Von Willebrand disease R1374C: Type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of Spain (Galicia)

American Journal of Hematology

Volumn 80, Issue 3, 2005, Pages 188-196

  Penas, Norma ^b   Pérez Rodríguez, Almudena ^b   Torea, Jorge Horacio ^b   Lourés, Esther ^b   Noya, María Soledad ^b   López Fernández, María Fernanda ^b   Batlle, Javier ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b NONE

Author keywords

Collagen binding assay; R1374C mutation; Subtypes 2A and 2M; Von Willebrand disease; VWF

Indexed keywords

COLLAGEN; RISTOCETIN;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DISEASE CLASSIFICATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BINDING; SPAIN; THROMBOCYTE ADHESION; VON WILLEBRAND DISEASE; VON WILLEBRAND DISEASE TYPE 2A; VON WILLEBRAND DISEASE TYPE 2M;

BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; CLASSIFICATION; COLLAGEN; DIAGNOSTIC ERRORS; DIMERIZATION; DNA MUTATIONAL ANALYSIS; EPIDEMIOLOGY, MOLECULAR; FACTOR VIII; FAMILY HEALTH; FEMALE; GENE FREQUENCY; HUMANS; MALE; MUTATION, MISSENSE; PEDIGREE; PLATELET FUNCTION TESTS; SPAIN; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 27644540337     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20470     Document Type: Article

References (23)

1. Von Willebrand EA. Hereditär pseudohemofili. Fin Laekaresaellsk Handl 1926;68:87-111.
2. Holmberg L, Nilsson IM. von Willebrand's disease. Eur J Haematol 1992;48:127-141.
3. Sadler JE. A revised classification of von Willebrand disease. For the subcommittee of von Willebrand Factor of the Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis. Thromb Haemost 1994;71:520-525.
4. Nitu-Whalley IC, Riddell A, Lee CA, et al. Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modelling. Thromb Haemost 2000;84:998-1004.
5. Budde U, Schneppenheim R. von Willebrand factor and von Willebrand disease. Rev Clin Exp Hematol 2001;5(4):335-361.
6. Batlle J, López Fernández MF. In: Zimmerman TS, Ruggeri ZM, editors. Coagulation and bleeding disorders: the role of FVIII and von Willebrand factor. New York: Marcel Dekker, Inc. 1989. p 325-342.
7. Federici AB, Canciani MT, Forza I, Cozzi G. Ristocetin cofactor and collagen binding normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease: single center comparison of four different assays. Thromb Haemost 2000;84:1127-1128.
8. Budde U, Schneppenheim R, Plendl H, Dent J, Ruggeri ZM, Zimmerman TS. Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes. Thromb Haemost 1990;63(2):312-315.
9. Kunkel LM, Smith KD, Boyer SH, et al. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci U S A 1977;74:1245-1249.
10. Federici AB, Mazurier C, Berntorp E, et al. Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study. Blood 2004;103:2032-2038.
11. Fressinaud E, Veyradier A, Truchaud F, et al. Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood 1998;91:1325-1331.
12. Mancuso DJ, Tuley EA, Westfield LA, et al. Structure of the gene for human von Willebrand factor. J Biol Chem 1989;264: 19514-19527.
13. Hilbert L, Gaucher C, Mazurier C. Identification of two mutations (Arg611Cys and Arg611His) in the A1 loop of von Willebrand factor (FVW) responsible for type 2 von Willebrand disease with decrease platelet-dependent function of VWF. Blood 1995;86:1010-1018.
14. Meyer D, Fressinaud E, Gaucher C, et al. Gene defects in 150 unrelated French cases with type 2 von Willebrand disease: from the patient to the gene. INSERM Network on Molecular Abnormalities in von Willebrand Disease. Thromb Haemost 1997;78:451-456.
15. Ribba AS, Hilbert L, Lavergne JM, Fressinaud E, Mazurier C, Meyer D. Mutations at position 513, 552, 611 and 695 in the A1 loop of von Willebrand factor induce a type 2A phenotype, usefulness of botrocetin to distinguish type 2A and 2M von Willebrand disease. Thromb Haemost 1999;(Suppl):510.
16. Casonato AJ, Pontara E, Sartorello F, Bertomoro A, Durante C, Girolami A. Type 2M von Willebrand disease variant characterized by abnormal von Willebrand factor multimerization. J Lab Clin Med 2001;137:70-76.
17. Hakami N, Shibuya H, Johnson GS, Stoy SI, Huang TH, Montgomery RR. A novel von Willebrand factor Arg611Cys or VWF Columbia associated with a dominant von Willebrand disease variant. Blood 1993;82:149a (abstract).
18. Favaloro EJ. Collagen binding assay for von Willebrand factor (VWF:CBA): detection of von Willebrand's disease (VWD), and discrimination of VWD subtypes depends on collagen sources. Thromb Haemost 2000;83:127-135.
19. Riddell AF, Jenkins PV, Nitu-Whalley IC, Mc Craw AH, Lee CA, Brown SA. Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay. Br J Haematol 2002; 116:187-192.
20. Castaman G, Federici AB, Rodeghiero F, Mannucci PM. von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica 2003;88:94-108.
21. Noya MS, Batlle J. Tratamiento de la enfermedad de von Willebrand. In: Batlle Fonrodona J, Rocha Hernando E, editors. Guía práctica de coagulopatías congénitas. Barcelona: Acción Médica S.A.; 2001. p 181-204.
22. Batlle J, Noya MS, Giangrande P, López Fernández MF. Advances in the therapy of von Willebrand disease. Haemophilia 2002;8:1-7.
23. Penas N, Perez A, Gonzalez-Boullosa R, Batlle J. C1272S: a new candidate mutation in type 2A von Willebrand disease that disrupts the disulfide loop responsible for the interaction of VWF with platelet GP 1b-1X. Am J Hematol 2004; 75:73-77.